Armata Pharmaceuticals, Inc. 10-K filing
Filed 2026-03-25 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001104659-26-034532
- Form type
- 10-K
- CIK
- 0000921114
- Primary document
- https://www.sec.gov/Archives/edgar/data/921114/000110465926034532/armp-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Armata Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-36.6M | - | - |
| Net Income | $-173.8M | - | - |
| Eps Basic | -4.8 | - | - |
| Eps Diluted | -4.8 | - | - |
| Cash And Equivalents | $8.7M | - | - |
| Total Assets | $76.9M | - | - |
| Total Liabilities | $295.5M | - | - |
| Shareholders Equity | $-218.6M | - | - |
| Operating Cash Flow | $-25.8M | - | - |
| Capital Expenditures | $542,000 | - | - |